Compounders Research Compare

Damora Therapeutics, Inc.(DMRA)

Biotechnology · Waltham, MA

$18.95-1.27 (-6.27%)

Delayed quote: Oct 6, 2026, 1:35 PM EDT

About Damora Therapeutics, Inc.

Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company’s lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of essential thrombocythemia; and DMR-002 and DMR-003, both anti-mutCALR-based therapies, with the intent to ultimately address the full spectrum of mutCALR MPN patients. It also develops GB3226, a small molecule inhibitor of ENL-YEATS and FLT3 for the treatment of acute myeloid leukemia. Damora Therapeutics, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.

Waltham, MA

7 employees

www.damoratx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Jennifer A. Jarrett

View full financials

Damora Therapeutics (DMRA) Earnings Yield: History & Chart | TGMCharts

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T17:36:14.934Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:36:14.934Z.

Quote observation: 2026-10-06T17:35:03.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -124.78
Quote price: 18.9524

FMP input reference: 4140271b5ba2e17517ffa776ba39ee0784cb590c71b20d0313403f3757235181

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

DMRA Earnings Yield Metrics

EARNINGS YIELD

N/A

DMRA Competitors' Earnings Yield

Damora Therapeutics, Inc.

Current

Market Cap

$1.17B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Nektar Therapeutics

Market Cap

$1.15B

Earnings Yield

N/A

TTM Avg

10.18%

3Y Avg

10.18%

5Y Avg

6.97%

Tyra Biosciences, Inc.

Market Cap

$1.19B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GoodRx Holdings, Inc.

Market Cap

$1.14B

Earnings Yield

1.29%

TTM Avg

2.76%

3Y Avg

2.15%

5Y Avg

2.02%

Amphastar Pharmaceuticals, Inc.

Market Cap

$1.14B

Earnings Yield

6.55%

TTM Avg

8.81%

3Y Avg

8.09%

5Y Avg

6.50%

Harrow Health, Inc.

Market Cap

$1.13B

Earnings Yield

N/A

TTM Avg

2.62%

3Y Avg

13.63%

5Y Avg

13.63%

ORIC Pharmaceuticals, Inc.

Market Cap

$1.21B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MannKind Corporation

Market Cap

$1.21B

Earnings Yield

N/A

TTM Avg

1.85%

3Y Avg

1.41%

5Y Avg

1.41%

Avalyn Pharma Inc. Common Stock

Market Cap

$1.13B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Tandem Diabetes Care, Inc.

Market Cap

$1.12B

Earnings Yield

N/A

TTM Avg

0.15%

3Y Avg

0.15%

5Y Avg

0.15%

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Damora Therapeutics, Inc. (DMRA)	$1.17B	N/A	N/A	N/A	N/A
Nektar Therapeutics (NKTR)vs ›	$1.15B	N/A	10.18%	10.18%	6.97%
Tyra Biosciences, Inc. (TYRA)vs ›	$1.19B	N/A	N/A	N/A	N/A
GoodRx Holdings, Inc. (GDRX)vs ›	$1.14B	1.29%	2.76%	2.15%	2.02%
Amphastar Pharmaceuticals, Inc. (AMPH)vs ›	$1.14B	6.55%	8.81%	8.09%	6.50%
Harrow Health, Inc. (HROW)vs ›	$1.13B	N/A	2.62%	13.63%	13.63%
ORIC Pharmaceuticals, Inc. (ORIC)vs ›	$1.21B	N/A	N/A	N/A	N/A
MannKind Corporation (MNKD)vs ›	$1.21B	N/A	1.85%	1.41%	1.41%
Avalyn Pharma Inc. Common Stock (AVLN)vs ›	$1.13B	N/A	N/A	N/A	N/A
Tandem Diabetes Care, Inc. (TNDM)vs ›	$1.12B	N/A	0.15%	0.15%	0.15%

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics